专利检索 ap:("KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY") AND inv:"Yun Ju Nam" 第 1 页

1.

发明授权
CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds 有权

公开(公告)号：US10130631B2

公开(公告)日：2018-11-20

申请号：US15677742

申请日：2017-08-15

申请人： KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

发明人： Tae Bo Sim , Ho Jong Yoon , Woo Young Hur , Yun Ju Nam , Hwan Geun Choi

IPC分类号： A61K31/506 , A61K31/519 , A61K31/5377

摘要： The present invention relates to a therapeutic agent for chronic myelogenous leukemia with reduced drug-resistance and side-effects containing a 1,6-disubstituted indole compound.

2.

发明授权
4-((2-acrylamidophenyl)amino)thieno[3,2-D]pyrimidine-7-carboxamide derivatives as protein kinase inhibitors 有权

公开(公告)号：US10040803B2

公开(公告)日：2018-08-07

申请号：US15821962

申请日：2017-11-24

申请人： KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY

发明人： Tae Bo Sim , Ho Jong Yoon , In Jae Shin , Yun Ju Nam , Hwan Geun Choi

IPC分类号： C07D495/02 , C07D495/04 , A61P35/00

CPC分类号： C07D495/04 , A61P35/00

摘要： The present invention relates to a novel 4-((2-acrylamidophenyl)amino)thieno[3,2-d]pyrimidine-7-carboxamide compound, an anticancer agent containing the compound as an active ingredient and an intermediate compound for preparing the compound.